FAQ/Help |
Calendar |
Search |
Today's Posts |
09-16-2009, 08:05 PM | #1 | |||
|
||||
Magnate
|
Michael J. Fox Foundation Commits Up to $12 Million for Targeted Parkinson's Therapeutic Development in 2010
Tue Sep 15, 2009 2:30pm EDT http://www.reuters.com/article/press...09+PRN20090915 NEW YORK, Sept. 15 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation has committed up to $12 million in 2010 funding for prioritized research toward transformative treatments and a cure for Parkinson's disease. Funding is open to academic and industry researchers through the Foundation's Pipeline Programs, which consist of three annually recurring initiatives, known collectively as The Edmond J. Safra Core Programs for PD Research, as well as the industry-exclusive Therapeutics Development Initiative. The Foundation seeks investigator-initiated proposals focused on the following critical points along the translational pathway to new therapies for Parkinson's disease:
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
Reply With Quote |
09-19-2009, 07:27 PM | #2 | |||
|
||||
Senior Member
|
I believe at last count, the Fox Foundation had put about $149 million into Parkinson's research! And they really haven't been in existence all that long.
Thank you, Thank you MJF!!! Peg |
|||
Reply With Quote |
09-20-2009, 05:19 PM | #3 | ||
|
|||
Member
|
Somehow I'm not very excited by the MJFF. I hope they do make some important contributions in the fight against PD but I wonder. I've tried in the past to bring their attention to low dose naltrexone, LDN, which many people take for MS but not very many with PD. One can go to the yahoo lowdosenaltrexone web site to see the thousands of anecdotal comments made for LDN but I prefer to believe in the research done at the NIH by Dr. Hongs Pharmacology group. They have produced many papers over the past 10 years on low doses of naltrexone, dextromethorphan and other similar compounds which have shown to greatly reduce over activated microglia (killer cells) in the brains of rodents. Over activated microglia are believed to be the latest cause of PD.
I have been taking LDN and Sinemet now for 5 years and 3 months. I still take a small amount of Sinemet and also a small amount of Mirapex. The overall mix has not been increased over this time. I now have ankle swelling and after reading the post here on Mirapex like drugs causing heart valve scarring, I now have something else to worry about. I have cut back recently on Mirapex on my own. I have a neuro apt. in 3 weeks, I wonder if she will own up to the potential disaster awaiting many of us. So if anyone can get MJF to talk to Dr. Hong, I would be more positive about his foundation. Ashley http://www.fasebj.org/cgi/content/full/19/6/550 http://jpet.aspetjournals.org/cgi/content/full/304/1/1 http://jpet.aspetjournals.org/cgi/co...urnalcode=jpet |
||
Reply With Quote |
09-20-2009, 10:22 PM | #4 | ||
|
|||
Member
|
ashley, I've known for some time that pergolide (permax) was implicated in heart valve damage. I looked up more information, and it's the ergot-derived dopamine agonists (permax and cabergoline) that cause the valve damage. Mirapex is a non-ergot agonist, so it's okay for your heart (so far, anyway!).
|
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
MJFF funds million dollars for GDNF delivery | Parkinson's Disease | |||
MJFox Foundation Awards $2.4 Million For Validation Of Nine Therapeutic Targets | Parkinson's Disease | |||
Targeted Genetics Corporation Recommended for up to $2.4 Million in Funding by Depart | ALS News & Research | |||
MJFF: Commits up to $2 million to Visualize Alpha-Synuclein Protein in the Brain | Parkinson's Disease | |||
MJFFoundation Commits Up to $2 Million to Improve Drug Delivery for PD | Parkinson's Disease |